122 related articles for article (PubMed ID: 10670214)
21. Hyperhomocysteinemia: marker of systemic atherosclerosis in peripheral arterial disease.
Taute BM; Taute R; Heins S; Behrmann C; Podhaisky H
Int Angiol; 2004 Mar; 23(1):35-40. PubMed ID: 15156128
[TBL] [Abstract][Full Text] [Related]
22. VEGF levels in patients with peripheral arterial occlusive disease receiving LDL-apheresis.
Ferrero S
J Clin Apher; 2004; 19(3):160; author reply 161. PubMed ID: 15493053
[No Abstract] [Full Text] [Related]
23. Stenting the chronic totally occluded superficial femoral artery: endovascular clinical benefit.
Garcia LA
J Invasive Cardiol; 2006 Jul; 18(7):322-3. PubMed ID: 16816438
[No Abstract] [Full Text] [Related]
24. Hyperhomocysteinemia and lower extremity wounds.
Schwartzfarb EM; Romanelli P
Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
[TBL] [Abstract][Full Text] [Related]
25. [Use of ticlopidine in a group of patients with obliterative arteriopathy of the lower extremities].
Gemelli A; Leone G; Berni A; Pacelli M
Clin Ter; 1987 Jul; 122(2):89-91. PubMed ID: 2973905
[No Abstract] [Full Text] [Related]
26. [Comparison between L-propionyl carnitine and physical-rehabilitative exercise in diabetics with obliterative arteriopathy of the legs (Fontaine's stage IIa)].
Costanza G; Di Salvo A; Barone G; Verruso G; Zamueli M; Marchese G
Minerva Cardioangiol; 1999 Dec; 47(12):649-50. PubMed ID: 10670244
[No Abstract] [Full Text] [Related]
27. [The still underused richness of thermal baths, epidemiology: apropos of a survey conducted at Royat on obliterative arteriopathy of the legs].
Duchêne-Marullaz P; Fabry R; Delahaye R; Trolèse JF; Ponsonnaille J; Schaff G
Bull Acad Natl Med; 1988 Jun; 172(6):763-8. PubMed ID: 3056588
[No Abstract] [Full Text] [Related]
28. Double jeopardy: how soluble P-selectin activates leukocytes in peripheral arterial occlusive disease.
Galkina E; Ley K
Circ Res; 2006 Jan; 98(1):12-4. PubMed ID: 16397153
[No Abstract] [Full Text] [Related]
29. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
Allegra C; Antignani PL; Schachter I; Koverech A; Messano M; Virmani A
Ann Vasc Surg; 2008; 22(4):552-8. PubMed ID: 18502605
[TBL] [Abstract][Full Text] [Related]
30. [Risks of extensive bladder surgery in subjects with chronic obliterative arteriopathy of the legs].
Caramia G; Giuntini G; Talarico F; Serretta V; Pavone Macaluso M
Minerva Urol Nefrol; 1988; 40(1):1-6. PubMed ID: 3175786
[No Abstract] [Full Text] [Related]
31. Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease.
Tsakiris DA; Tschöpl M; Wolf F; Labs KH; Jäger KA; Marbet GA
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):165-73. PubMed ID: 10759010
[TBL] [Abstract][Full Text] [Related]
32. [Possibilities and limitations of Doppler flowmetry in the clinical evaluation of chronic obstructive arteriopathy of the legs. Our case material].
Galati G; Rengo M; Terrinoni V; Capaldi M; Anelli L; Ercolani GE; Borghese M
Minerva Chir; 1987 Mar; 42(6):497-501. PubMed ID: 2956534
[No Abstract] [Full Text] [Related]
33. [Is obliterating arteriopathy of the lower limbs still the poor member of the arterial disease family? What can be done?].
Blacher J
J Mal Vasc; 2007 Apr; 32(2):73-4. PubMed ID: 17498900
[No Abstract] [Full Text] [Related]
34. [Markers predicting progression of disease in PAD: Which of them are both relevant to clinical practice and economically justifiable?].
Taute BM
Hamostaseologie; 2006 Aug; 26(3):201-7. PubMed ID: 16906236
[TBL] [Abstract][Full Text] [Related]
35. Proceedings: Gravimetric plethysmography in patients with occlusive vascular disease of the legs.
Jackson JR; Matthews JA
Br J Surg; 1976 Feb; 63(2):155-6. PubMed ID: 1252741
[No Abstract] [Full Text] [Related]
36. [Thrombophilias and peripheral arterial occlusive disease].
Le Hello C; Blacher J; Conard J; Piette JC; Constans J
J Mal Vasc; 2008 Sep; 33(3):126-36. PubMed ID: 18554834
[TBL] [Abstract][Full Text] [Related]
37. [Hemocoagulative and fibrinolytic parameters in chronic obliterative vascular disease of the lower extremities].
Avellone G; Abruzzese G; Mandalà V; Riolo FP; Fazio M
Boll Soc Ital Cardiol; 1980; 25(1):43-6. PubMed ID: 6165368
[No Abstract] [Full Text] [Related]
38. Preliminary results of the effect of treatment of hyperhomocysteinemia and its relationship with inflammation, coagulation status, and endothelial function after renal transplantation.
Manrique J; Diáz A; Gavira JJ; Hernández A; Pujante D; Errasti P
Transplant Proc; 2005 Nov; 37(9):3782-4. PubMed ID: 16386537
[TBL] [Abstract][Full Text] [Related]
39. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
Tallarida G; Baldoni F; Peruzzi G; Raimondi G; Grimaldi I; Visigalli G; Gristina S; Massaro M; De Martinis L; Sangiorgi M
Cardiologia; 1983 Aug; 28(8):651-60. PubMed ID: 6687209
[No Abstract] [Full Text] [Related]
40. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
